EUROAPI

Paris, France
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ✓ Press (10) ○ EMA GMP ○ MHRA GMP

Quick Facts: EUROAPI

Signal Score
60.0/100
Quality Compliance
Assessment pending
Headquarters
Paris, France
Modalities
Prostaglandin API, Small Molecule API, Steroids/Hormones, Peptides, Oligonucleotides, Microbial Fermentation
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

Signal Score & Pillar Breakdown

Quality Compliance
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs no verified data
Sponsorsno verified data
ModalitiesProstaglandin API, Small Molecule API, Steroids/Hormones, Peptides, Oligonucleotides, Microbial Fermentation
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity 60.0
Broad modality coverage (6 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press10 articles
Broad modality coverage (6 modalities)

Recent News 10 articles

news Wed, 15 Oc
Particle Dynamics melds with former EuroAPI plant to debut new CDMO Codis - Fierce Pharma
news Wed, 04 Ju
Frédéric Robert appointed EUROAPI’s Chief Commercial Officer overseeing API Solutions and CDMO activities - Yahoo Finance
news Tue, 29 Au
EUROAPI to Acquire BianoGMP for €10M - Contract Pharma
news Tue, 01 Ju
EuroAPI sheds UK facility as restructuring plan rolls on - Fierce Pharma
news Thu, 29 Fe
Euroapi Announces Restructuring Plan - DCAT Value Chain Insights
news Thu, 27 Ju
Euroapi, Sanofi’s Spinout CDMO Details Restructuring Plan, Including Mfg - DCAT Value Chain Insights
news Thu, 25 Ja
EUROAPI Enhances Its CDMO Capabilities Through a Pivotal Collaboration With SpiroChem, a Leading Contract Research Organization (CRO) - Business Wire
news Thu, 05 Ma
Sanofi’s Euroapi Launches as Stand-alone $1-Bn CDMO - DCAT Value Chain Insights
news Sat, 16 Ap
EuroAPI is ready to emerge from Sanofi’s shadow - C&EN
news Mon, 09 Oc
In cutting sales guidance, EuroAPI cites CDMO industry struggles and customers' inventory reductions - Fierce Pharma
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Prostaglandin API CDMOs → Small Molecule API CDMOs → Steroids/Hormones CDMOs → Peptides CDMOs → Oligonucleotides CDMOs → Microbial Fermentation CDMOs →

Similar CDMOs

Cayman Chemical / Cayman Pharma s.r.o.
Ann Arbor, MI (Cayman Chemical) / Neratovice, Czech Republic (Cayman Pharma)
Prostaglandin API, Small Molecule API, Psychedelic APIs, Cationic Lipids, Biochemicals
Cytovance Biologics
Oklahoma City, OK
Signal Score: 61.5
Microbial Fermentation, Biologics, Recombinant Proteins, Mammalian Cell Culture, Plasmid DNA